Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 270-695-5 | CAS number: 68476-55-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Toxicity to reproduction
Administrative data
- Endpoint:
- two-generation reproductive toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Near-guideline, GLP, animal experimental study, published in peer reviewed literature, minor limitations in design, adequate for assessment.
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 003
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 416 (Two-Generation Reproduction Toxicity Study)
- Deviations:
- yes
- Remarks:
- study pre-dates current guideline (2001) and does not assess sperm parameters or length of oestrous cycles
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- Toluene
- EC Number:
- 203-625-9
- EC Name:
- Toluene
- Cas Number:
- 108-88-3
- Molecular formula:
- C7H8
- IUPAC Name:
- toluene
- Details on test material:
- - Name of test material (as cited in study report): toluene
- Physical state: clear, colourless liquid
- Analytical purity: 99.9%
- Supplier: American Petroleum Institute, Washington, DC, USA
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Crl:CD[SD]BR
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Breeding Laboratories, Portage, MI, USA
- Age at study initiation: approximately 6 weeks
- Weight at study initiation: not reported
- Housing: individually in wire mesh cages or in plastic breeding cages with nesting material in 16m3 stainless steel and glass exposure chambers with adjoining anterooms. Two additional 16 m3 chambers housed pups during the lactation period.
- Diet (e.g. ad libitum): no details reported
- Water (e.g. ad libitum): no details reported
- Acclimation period: 2 weeks
ENVIRONMENTAL CONDITIONS
- Temperature: 23-24.1°C
- Humidity: 52-56%
- Air changes (per h): not reported
- Photoperiod: 12 h dark / 12 h light
IN-LIFE DATES: not reported
Administration / exposure
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure (if applicable):
- whole body
- Vehicle:
- other: air
- Details on exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: housed in 16 m3 exposure chambers throughout study
- System of generation: toluene was metered at controlled rates to a column where it was vaporised with heated nitrogen; concentrated vapours were diluted with chamber ventilation air to produce desired dose levels
TEST ATMOSPHERE
- Brief description of analytical method used: gas phase spectrophotometry using a Miran infrared analyzer
- Samples taken from breathing zone: yes
- Nominal concentrations were determined from weight of test material used divided by total volume of airflow in each chamber during exposure. - Details on mating procedure:
- - M/F ratio per cage: 2 females:1male
- Length of cohabitation: maximum of 15 days
- Proof of pregnancy: vaginal lavage. Day on which evidence of copulation was observed was designated day 1 of gestation (GD1) - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Actual exposure concentrations were determined at hourly intervals by gas phase spectrophotometry using a Miran infrared analyser
- Duration of treatment / exposure:
- 6 h/day
- Frequency of treatment:
- 7 days/week
- Details on study schedule:
- Adults of both the F0 and Fl generations were exposed for 6h/day, 7 days/week during 80 days premating and 15-day mating period. F0 and Fl males were not exposed after completion of the mating period. Presumed pregnant females of both generations were exposed from gestation day (GD)
1-20 and lactation day (LD) 5-21. At day 5 of lactation, females were removed from their litters, exposed for 6 h/day, 7 days/week, and returned to the litters following daily exposure. Parental females were not exposed after litters had been weaned. F1 pups selected to produce the F2 generation
were treated for a minimum of 80 days beginning immediately after weaning, and initially mated at a minimum of 100 days of age. F2 pups were not exposed to toluene by inhalation. Target exposure concentrations were 0, 100, 500 and 2000 ppm (0, 375, 1875 and 7500mg/m) for parental animals of both sexes and 2000 ppm to males or females mated to untreated partners.
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
0, 375, 1875, 7500 mg/m3
Basis:
other: target concentration
- Remarks:
- Doses / Concentrations:
0, 102, 497, 2020 ppm
Basis:
analytical conc.
average over 39 weeks of exposure
- No. of animals per sex per dose:
- F0 generation (parental): 30, 10, 10, 20, 10, 10 males and 60, 20, 20, 40, 20, 20 females for the 0, 100, 500, 2000, 2000 (females untreated) and 2000 (males untreated) groups respectively.
F1 generation: 19, 10, 10, 10, 10, 10 males and 40, 20, 19, 19, 20, 20 females for the 0, 100, 500, 2000, 2000 (females untreated) and 2000 (males untreated) groups respectively. - Control animals:
- yes, sham-exposed
- Details on study design:
- There were three 2000 ppm groups. In one group males and females were exposed, in the second the females were not exposed but were mated with exposed males, in the third the males were not exposed but were mated with exposed females.
Examinations
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: twice daily, before and after exposure for signs of overt toxicity, changes in general appearance and mortality
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: weekly on F0 parental rats and F1 pups selected for mating
BODY WEIGHT: Yes
- Time schedule for examinations: weekly for adult rats. Mated females were weighed on GD 1, 7, 14, and 21 and on LD 1, 4, 14, and 21
FOOD CONSUMPTION: Yes
- Time schedule for examinations: Parental food consumption was measured weekly from initiation to termination of each generation except during mating, and calculated as group mean food consumption (by sex) in units of g/rat/day and g/kg body weight/day
WATER CONSUMPTION: No - Oestrous cyclicity (parental animals):
- Confirmation of oestrus (normal cycling) among adult F0 and Fl females was determined by vaginal lavage daily during mating period
- Sperm parameters (parental animals):
- Not assessed
- Litter observations:
- STANDARDISATION OF LITTERS: No
CAESARIAN DATA: On day 21 of gestation, 20 mated F0 females from control and 2000 ppm (both sexes treated) groups were killed, uteri were removed, weighed (with and without foetal content) and foetal contents examined. The following were recorded: number and location of viable and non-viable foetuses, early and late resorptions, number of total implantations and corpora lutea; the number, condition, sex, location and weight of each live and dead foetus, and external alterations and malformations of live foetuses.
REPRODUCTIVE AND LITTER EVALUATIONS: All females not selected for Caesarean section, were put into individual delivery cages and examined twice daily for signs of parturition. The day on which all pups were delivered was designated day 1 of lactation (LD). Parameters recorded included: male and female fertility indices, length of cohabitation (copulatory interval), gestation period, abnormalities in nesting and nursing behaviour, difficulties at parturition, mean number of live and stillborn pups per litter, pup survival through weaning, pup weight at birth and during lactation, and general appearance and behaviour.
PUP BODY WEIGHT: Pups were individually weighed on LD 1, 4, 14, and 21.
PUP CLINICAL SIGNS: Animals were observed twice daily, before and after exposure, for signs of overt toxicity, changes in general appearance and mortality. Detailed observations were recorded weekly on F1 pups selected for mating. Examinations of Fl and F2 pups for gross deformities
were conducted on days 1, 4, 14, and 21 of lactation. - Postmortem examinations (parental animals):
- All adult animals dying or killed moribund were necropsied. Reproductive organs and gross lesions were examined from all selected parental animals.
- Postmortem examinations (offspring):
- One pup/sex/litter from F1 and F2 weanlings (control and 2000 ppm groups) selected for histopathology. Half of F0 and F1 males per group were necropsied with histopathology after the mating period; remaining males were retained untreated and necropsied 3 weeks after the end of the mating period. All F0 and Fl females that delivered pups were necropsied with histopathology at weaning on day 21 of lactation.
The following were examined from selected F1 and F2 weanlings: gross lesions, adrenals, bone marrow, brain, colon, duodenum, eyes, epididymides, heart, ileum, liver, lung, lymph node, mammary gland, ovaries, pancreas, salivary gland, seminal vesicles, skeletal muscle, skin, cervical spinal cord, spleen, stomach, testes, thyroid, urinary bladder, uterus, prostate, and thymus. - Statistics:
- Body weight, body weight gain, food consumption, live pups and foetuses, pup and foetal body weight analysed by one-way ANOVA followed by Bartlett's test for homogeneity of variance and appropriate t-test (i.e. equal or unequal variance). Dose-response relationships assessed using simple linear regression. Early/late resorptions, dead foetuses, post-implantation loss and pup survival indices analysed using the Mann-Whitney U-test and Jonckheere's test. Fertility indices, pregnancy rates, malformations, sex ratios analysed using Fisher's exact test and the Armitage test for linear trend in proportions. The litter was the experimental unit.
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Body weight and weight changes:
- effects observed, treatment-related
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- not examined
- Reproductive function: sperm measures:
- not examined
- Reproductive performance:
- no effects observed
Effect levels (P0)
open allclose all
- Dose descriptor:
- NOAEC
- Remarks:
- systemic toxicity
- Effect level:
- 500 ppm
- Sex:
- male/female
- Basis for effect level:
- other: slightly lower body weight gain 2000 ppm
- Dose descriptor:
- NOAEC
- Remarks:
- systemic toxicity
- Effect level:
- 1 875 mg/m³ air (nominal)
- Sex:
- male/female
- Basis for effect level:
- other: slightly lower bodyweight gain at 7500 mg/m3
- Dose descriptor:
- NOAEC
- Remarks:
- reproduction
- Effect level:
- 2 000 ppm
- Sex:
- male/female
- Basis for effect level:
- other: no effects on fertility, reproductive performance or maternal/ pup behaviours at 2000 ppm (highest dose tested)
- Dose descriptor:
- NOAEC
- Remarks:
- reproduction
- Effect level:
- 7 500 mg/m³ air (nominal)
- Sex:
- male/female
- Basis for effect level:
- other: no effects on fertility, reproductive performance or maternal/ pup behaviours at 7500 mg/m3 (highest dose tested)
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- effects observed, treatment-related
- Sexual maturation:
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Histopathological findings:
- no effects observed
Effect levels (F1)
open allclose all
- Dose descriptor:
- NOAEC
- Generation:
- F1
- Effect level:
- 500 ppm
- Sex:
- male/female
- Basis for effect level:
- other: lower body weight at birth and body weight gain prior to weaning
- Dose descriptor:
- NOAEC
- Generation:
- F1
- Effect level:
- 1 875 mg/m³ air (nominal)
- Sex:
- male/female
- Basis for effect level:
- other: lower body weight at birth and body weight gain prior to weaning
Results: F2 generation
Effect levels (F2)
open allclose all
- Dose descriptor:
- NOAEC
- Generation:
- F2
- Effect level:
- 500 ppm
- Sex:
- male/female
- Basis for effect level:
- other: lower body weight at birth and body weight gain prior to weaning
- Dose descriptor:
- NOAEC
- Generation:
- F2
- Effect level:
- 1 875 mg/m³ air (nominal)
- Sex:
- male/female
- Basis for effect level:
- other: lower bodyweight at birth and body weight gain prior to weaning
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Any other information on results incl. tables
Analysis
of the chamber atmospheres demonstrated that actual exposures were
within 1-2% of nominal.
ADULT OBSERVATIONS
There were no toluene-related deaths in either parental generation.
Body weight gain was decreased slightly in mid- and high dose F0 males
during the first 3 weeks of treatment but was unremarkable thereafter. Similar
decrements were present in F1 animals of both sexes throughout the
exposure period, with statistically significant effects intermittently
present in this instance. Similar decreases, with occasional statistical
significance, were also present in females during the lactation period.
Representative mean body weight data for females from control and high
dose females is summarised below:
(Table based on Roberts L et al 2003, Reproductive Toxicology, 17, 649-658,Table 3)
|
F0 females |
F1 females |
||||||
0 |
H(a) |
H(b) |
H(c) |
0 |
H(a) |
H(b) |
H(c) |
|
GD1 |
257 |
255 |
262 |
244 |
269 |
240 |
266 |
238 |
GD7 |
283 |
280 |
281 |
265 |
296 |
267 |
288 |
261 |
GD14 |
310 |
308 |
311 |
290 |
322 |
294 |
318 |
290 |
GD21 |
373 |
367 |
370 |
348 |
389 |
346 |
383 |
347 |
LD1 |
297 |
290 |
301 |
277 |
307 |
276 |
298 |
272 |
LD4 |
295 |
275 |
299 |
272 |
312 |
285 |
308 |
281 |
LD14 |
324 |
312 |
326 |
294 |
329 |
287 |
323 |
290 |
LD21 |
321 |
306 |
316 |
296** |
318 |
284** |
315 |
286** |
H = high dose (2000 ppm) (a) both sexes treated (b) males only treated (c) females only treated * P , 0.05, ** P < 0.01 |
Comment:
the authors note that F1 females showed a slight but consistent
reduction in body weight throughout their life, which appeared to a
correlate with reduced growth when they were pups linked to continued
lower body weight as they matured into adults.
Maternal behaviour and food intake was comparable over the groups.
Dams from the 2000 ppm caesarean section group had terminal body weights
comparable to controls with no significant differences in liver or
kidney weights. Mean intact uterine weight was lower in the 2000 ppm
females (65.9 g) than controls (69.8 g) reflecting low foetal weights.
respectively).
Fertility indices, duration of mating and gestational length were
comparable among the groups.
FOETAL OBSERVATIONS
Foetal body weights were significantly lower in the 2000 ppm group
relative to the controls (3.3 versus 3.6 g; p<0.01), with more
developmental variations present in the treated animals (88 foetuses in
17 litters) than the controls (57 foetuses in 18 litters). The incidence
of skeletal variations, rudimentary ribs and unossified sternebrae was
increased in the 2000 ppm groups, but considered by the authors to be
related to the lower foetal body weight:
|
0 ppm |
2000 ppm (a) |
No. of skeletal examinations |
117 |
112 |
Rudimentary ribs |
17(10) |
34(11) |
Unossified sternebrae |
32(13) |
57(14) |
Total developmental variations |
57(18) |
88(17) |
Results
presented as number of foetuses exhibiting variations (number of litters
affected in brackets)
(a) Both sexes treated
No
statistically significant differences
OFFSPRING OBSERVATIONS
Pup viability, mean litter size and lactational survival were comparable
among the groups. Body weight gain of high dose group pups of both sexes
was significantly less than the controls throughout lactation in both F1
and F2 generations.
HISTOPATHOLOGY
Microscopic examination of 29 tissues from selected control and high
dose animals in the F0, F1 and F2 generations found no treatment-related
effects.
Applicant's summary and conclusion
- Conclusions:
- The results indicate a reproductive NOAEC of at least 2000 ppm (7500 mg/m3), a parental NOAEC of 500 ppm (1875 mg/m3) based on marginally decreased body weight, an offspring NOAEC of 500 ppm (1875 mg/m3) based on decreased body weight/weight gain and a foetal/developmental NOAEC of 500 ppm (1875 mg/m3) based on decreased foetal weight and increased skeletal variations.
- Executive summary:
Reproductive and developmental toxicity of toluene was assessed in a combined two-generation fertility and teratogenicity inhalation study in groups of at least 10 male and 20 female Crl:CD[SD]BR rats. Exposure to toluene was at 0, 100, 500 or 2000 ppm (0, 375, 1875 or 7500 mg/m3) 6 h/day, 7 days/week during an 80 day pre-mating period and 15 day mating period. Females were further exposed on GD 1 -20 and LD 5 -21.
Toluene exposure did not induce adverse effects on fertility, reproductive performance, or maternal/pup behaviours during the lactation period in males and females of the parental or first generation. Caesarean section of selected 2000 ppm (both sexes treated) dams at GD 20 showed reduced foetal body weight and skeletal variations. Maternal exposure to toluene at 2000 ppm caused decreased pup weights throughout lactation in F1 and F2 animals.
Overall the NOAEC for parental toxicity and off-spring toxicity was 500 ppm (1875 mg/m3). The NOAEC for effects on fertility was 2000 ppm (7500 mg/m3), the highest dose tested.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
